Partnership for Parkinson's disease research: Patient-researcher-clinician-sponsor

被引:3
|
作者
Olden, K [1 ]
Guthrie, J [1 ]
Lawler, C [1 ]
机构
[1] NIEHS, Res Triangle Pk, NC 27709 USA
关键词
Parkinson's disease; environment; consortium; oxidative stress;
D O I
10.1016/S0161-813X(02)00030-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) appears to arise from the interaction of three events-an individual's inherited genetic susceptibility, their subsequent environmental exposures, and their age. We clearly need to intensify efforts to understand the environmental triggers of PD, the importance of the timing of exposure to these triggers, and the interplay between these exposures and a persons underlying genetic constitution and susceptibilities. This knowledge, once generated, will lead to better detection of the earliest stages of PD, to improved therapeutics, and most importantly, to viable prevention strategies so that people need not suffer from environmentally-caused PD. Many promising lines of investigation are already supported by the National Institute of Environmental Health Sciences (NIEHS), National Institute of Neurological Disorders and Stroke (NINDS), and the National Institute of Aging (NIA) and other public and private organizations. In order to accelerate the pace of progress in this field, the NIEHS is developing a Consortium Centers Program that will provide a formal mechanism for "cross-talk" between PD clinicians, basic research scientists, and patient advocates. The Consortium will seek to identify and support novel approaches and research ventures that might not otherwise be pursued by scientists working in isolation. The NIEHS will also continue to explore ways to promote more mechanism-based research to understand putative environmental triggers for PD in concert with defined genetic susceptibilities. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:451 / 456
页数:6
相关论文
共 50 条
  • [21] Patient advisory boards: A model for patient engagement in Parkinson's disease comparative effectiveness research
    Schroeder, K.
    Gallagher, C.
    Armstrong, M.
    Carnie, M.
    Evers, C.
    Fleisher, J.
    Kluger, B.
    Lamb, J.
    Seshadri, S.
    Wilson, L.
    Feeney, M.
    Davies, P.
    MOVEMENT DISORDERS, 2022, 37 : S352 - S352
  • [22] αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson's Disease?
    Protter, David
    Lang, Charmaine
    Cooper, Antony A.
    PARKINSONS DISEASE, 2012, 2012
  • [23] Parkinson's Disease and the Orthopaedic Patient
    Zuckerman, Lee M.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2009, 17 (01) : 48 - 55
  • [24] A patient's journey - The reluctant patient: Parkinson's disease
    Helsing, Elisabet
    BRITISH MEDICAL JOURNAL, 2007, 335 (7627): : 989 - 990
  • [25] Gastroparesis in a patient with Parkinson's disease
    Sangha, Maheep
    Arora, Alok
    Shulman, Keith
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2016, 77 (05) : 311 - 311
  • [26] Melanoma in a patient with Parkinson's disease
    Garrido, C.
    Gallego, S.
    Vanaclocha, F.
    Ortiz, P. L.
    ACTAS DERMO-SIFILIOGRAFICAS, 2009, 100 (04): : 331 - 332
  • [27] Parkinson's disease as seen by a patient
    García-Martínez, JC
    REVISTA DE NEUROLOGIA, 2003, 37 (04) : 391 - 400
  • [28] Parkinson's disease in the older patient
    Lewis, Simon J.
    Gangadharan, Sanjay
    Padmakumar, Chandrasekhara Pillai
    CLINICAL MEDICINE, 2016, 16 (04) : 376 - 378
  • [29] A patient-clinician James Lind Alliance partnership to identify research priorities for hyperemesis gravidarum
    Dean, Caitlin R.
    Bierma, Hyke
    Clarke, Ria
    Cleary, Brian
    Ellis, Patricia
    Gadsby, Roger
    Gauw, Norah
    Lodge, Karen
    MacGibbon, Kimber
    McBride, Marian
    Munro, Deirdre
    Nelson-Piercy, Catherine
    O'Hara, Margaret
    Penny, Helen
    Shorter, Katherine
    Spijker, Rene
    Trovik, Jone
    Watford, Emma
    Painter, Rebecca C.
    BMJ OPEN, 2021, 11 (01):
  • [30] Zoophilia in a patient with Parkinson's disease
    Fornelos, A.
    Roque, M.
    EUROPEAN PSYCHIATRY, 2017, 41 : S632 - S632